Search Icon
SideMenu

Resources

Find up-to-date information on generics and biosimilars

  • Reset
  • Press Releases

Hikma Breaks Ground on Expanded U.S. Manufacturing and Announces $1 Billion Investment
  • Press Releases

Eighth Circuit Court Rules Unanimously for AAM in Generic Pricing Appeal
  • Blog

$423B Savings from Patent Settlements Since Actavis Ruling
  • Blog

Patent Settlements Are Necessary To Help Combat Patent Thickets
  • Press Releases

Generic and Biosimilar Patent Settlements Save $423 Billion
  • Press Releases

AAM Comments on Section 232 Investigation on Pharmaceuticals
  • Press Releases

AAM Commends Senate Q1/Q2 Bill Introduction
  • Press Releases

AAM Congratulates Dr. Oz on Confirmation as Administrator of the Centers for Medicare & Medicaid Services
  • Press Releases

AAM Comments on staff layoffs at FDA
  • Press Releases

AAM Congratulates FDA Commissioner Makary
  • Press Releases

AAM Commends Q1/Q2 House Bill Reintroduction
  • Press Releases

Association for Accessible Medicines on Confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services

Generics

are a proven prescription for a healthier society.

Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.

Learn More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe

© 2025 Association for Accessible Medicines (AAM), All Rights Reserved
Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram